The collaboration allows HGS to develop 4-Antibody’s proprietary in vitro Retrocyte Display technology (Retroviral B lymphocyte Display) to discover sources for antibody drug candidates. Retrocyte Display creates therapeutic
China Ruitai’s net income was $1.37m, compared to net income of $1.42m for the same period in the prior year. The company’s income from operations was $2.46m for
Revenue from the chemical products segment was $12.1m, or 23% of total revenue, for the second quarter of 2011, an increase of 3%from $11.8m in the corresponding period
The preclinical study results demonstrated that ME-143 showed anti-tumor activity against tumor cell lines, including breast, colorectal and ovarian. Additionally, ME-143 has also shown an ability to enhance
The milestone was paid for achieving key scientific milestones following independent scientific review of the company’s ongoing R&D projects. The payment is part of the previously announced five-year,
The Complete EHRs are 2011/2012 compliant and have been certified by InfoGard Laboratories, an ONC-ATCB certification body. Axolotl EMR Lite aids physicians to connect with the HIE and
The new plant will engaged in the manufacturing of premium powdered milk products for Chinese infants and children. Abbott expects to recruit around 300 people in the new
Eisai Laboratorios (Eisai Mexico) initially will focus to establish strategies and an initial infrastructure to support its operations debut into the Mexican market. It is the company’s second
The application was submitted to FDA on the basis of results from a 24-week study assessing 84 patients with central precocious puberty. In the trial, the enrolled patients
The report, ‘Pharmaceutical Contract Manufacturing: World Market Outlook 2011-2021,’ says that the market will grow with a CAGR of 8.7% between 2010 and 2016, with finished dosage forms
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.